| Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease TJ MacDonald, KM Brown, B LaFleur, K Peterson, C Lawlor, Y Chen, ... Nature genetics 29 (2), 143-152, 2001 | 579 | 2001 |
| Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α CA Thorne, AJ Hanson, J Schneider, E Tahinci, D Orton, CS Cselenyi, ... Nature chemical biology 6 (11), 829-836, 2010 | 542 | 2010 |
| Orthogonal SARS-CoV-2 serological assays enable surveillance of low-prevalence communities and reveal durable humoral immunity TJ Ripperger, JL Uhrlaub, M Watanabe, R Wong, Y Castaneda, ... Immunity 53 (5), 925-933. e4, 2020 | 430 | 2020 |
| Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States TD Simon, M Hall, J Riva-Cambrin, JE Albert, HE Jeffries, B LaFleur, ... Journal of Neurosurgery: Pediatrics 4 (2), 156-165, 2009 | 311 | 2009 |
| MeCP2 mutations in children with and without the phenotype of Rett syndrome K Hoffbuhr, JM Devaney, B LaFleur, N Sirianni, C Scacheri, J Giron, ... Neurology 56 (11), 1486-1495, 2001 | 289 | 2001 |
| An expression signature classifies chemotherapy-resistant pediatric osteosarcoma MB Mintz, R Sowers, KM Brown, SC Hilmer, BA Mazza, AG Huvos, ... Cancer research 65 (5), 1748-1754, 2005 | 261 | 2005 |
| Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine KA Poehling, PG Szilagyi, CG Grijalva, SW Martin, B LaFleur, E Mitchel, ... Pediatrics 119 (4), 707-715, 2007 | 257 | 2007 |
| Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy RT Shroff, P Chalasani, R Wei, D Pennington, G Quirk, MV Schoenle, ... Nature Medicine, 1-10, 2021 | 246* | 2021 |
| Hospital-reported medical errors in children AD Slonim, BJ LaFleur, W Ahmed, JG Joseph Pediatrics 111 (3), 617-621, 2003 | 237 | 2003 |
| Restaurant inspection scores and foodborne disease TF Jones, BI Pavlin, BJ LaFleur, LA Ingram, W Schaffner Emerging Infectious Diseases 10 (4), 688, 2004 | 236 | 2004 |
| Gene expression correlates of neurofibrillary tangles in Alzheimer's disease T Dunckley, TG Beach, KE Ramsey, A Grover, D Mastroeni, DG Walker, ... Neurobiology of aging 27 (10), 1359-1371, 2006 | 222 | 2006 |
| Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma KI Amiri, LW Horton, BJ LaFleur, JA Sosman, A Richmond Cancer Research 64 (14), 4912-4918, 2004 | 206 | 2004 |
| A molecular signature of gastric metaplasia arising in response to acute parietal cell loss K Nozaki, M Ogawa, JA Williams, BJ Lafleur, V Ng, RI Drapkin, JC Mills, ... Gastroenterology 134 (2), 511-522, 2008 | 203 | 2008 |
| Racial and income disparities in childhood asthma in the United States LJ Akinbami, BJ LaFleur, KC Schoendorf Ambulatory Pediatrics 2 (5), 382-387, 2002 | 191 | 2002 |
| Women subjects in NIH-funded clinical research literature: lack of progress in both representation and analysis by sex RM Vidaver, B Lafleur, C Tong, R Bradshaw, SA Marts Journal of women's health & gender-based medicine 9 (5), 495-504, 2000 | 189 | 2000 |
| Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer HJ Lee, KT Nam, HS Park, MA Kim, BJ LaFleur, H Aburatani, HK Yang, ... Gastroenterology 139 (1), 213-225. e3, 2010 | 184 | 2010 |
| Overexpression of the EGFR/FKBP12/HIF-2α pathway identified in childhood astrocytomas by angiogenesis gene profiling S Khatua, KM Peterson, KM Brown, C Lawlor, MR Santi, B LaFleur, ... Cancer research 63 (8), 1865-1870, 2003 | 182 | 2003 |
| Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine NB Halasa, A O'Shea, JR Shi, BJ LaFleur, KM Edwards The Journal of pediatrics 153 (3), 327-332. e1, 2008 | 172 | 2008 |
| Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma ML Rothenberg, B LaFleur, DE Levy, MK Washington, ... Journal of Clinical Oncology 23 (36), 9265-9274, 2005 | 169 | 2005 |
| Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect MJ Levin, D Barber, E Goldblatt, M Jones, B LaFleur, C Chan, D Stinson, ... The Journal of infectious diseases 178 (Supplement_1), S109-S112, 1998 | 169 | 1998 |